Eichhorn PJA - Search Results

1

Influence of Epithelial-Mesenchymal Transition on Risk of Relapse and Outcome to Eribulin or Cyclin-Dependent Kinase Inhibitors in Metastatic Breast Cancer.

Chan A, Gill J, Chih H, Wright SCE, Vasilevski N, Eichhorn PJA. Chan A, et al. Among authors: eichhorn pja. JCO Precis Oncol. 2024 Dec;8:e2400274. doi: 10.1200/PO.24.00274. Epub 2024 Dec 6. JCO Precis Oncol. 2024. PMID: 39642326 Free PMC article.

2

Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity.

Wright SCE, Vasilevski N, Serra V, Rodon J, Eichhorn PJA. Wright SCE, et al. Among authors: eichhorn pja. Cancers (Basel). 2021 Mar 26;13(7):1538. doi: 10.3390/cancers13071538. Cancers (Basel). 2021. PMID: 33810522 Free PMC article. Review.

3

SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition.

Lai X, Lui SKL, Lam HY, Adachi Y, Sim WJ, Vasilevski N, Armstrong NJ, Bridgeman SC, Main NM, Tan TZ, Tirnitz-Parker JEE, Thiery JP, Ebi H, Kumar AP, Eichhorn PJA. Lai X, et al. Among authors: eichhorn pja. NPJ Precis Oncol. 2023 Dec 15;7(1):136. doi: 10.1038/s41698-023-00486-6. NPJ Precis Oncol. 2023. PMID: 38102334 Free PMC article.

4

OTUD4 enhances TGFβ signalling through regulation of the TGFβ receptor complex.

Jaynes PW, Iyengar PV, Lui SKL, Tan TZ, Vasilevski N, Wright SCE, Verdile G, Jeyasekharan AD, Eichhorn PJA. Jaynes PW, et al. Among authors: eichhorn pja. Sci Rep. 2020 Sep 24;10(1):15725. doi: 10.1038/s41598-020-72791-0. Sci Rep. 2020. PMID: 32973272 Free PMC article.

5

TGF-β, EMT, and resistance to anti-cancer treatment.

Wang X, Eichhorn PJA, Thiery JP. Wang X, et al. Among authors: eichhorn pja. Semin Cancer Biol. 2023 Dec;97:1-11. doi: 10.1016/j.semcancer.2023.10.004. Epub 2023 Nov 8. Semin Cancer Biol. 2023. PMID: 37944215 Free article. Review.

6

c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression.

Sim WJ, Iyengar PV, Lama D, Lui SKL, Ng HC, Haviv-Shapira L, Domany E, Kappei D, Tan TZ, Saei A, Jaynes PW, Verma CS, Kumar AP, Rouanne M, Ha HK, Radulescu C, Ten Dijke P, Eichhorn PJA, Thiery JP. Sim WJ, et al. Among authors: eichhorn pja. Nat Commun. 2019 Sep 25;10(1):4349. doi: 10.1038/s41467-019-12241-2. Nat Commun. 2019. PMID: 31554791 Free PMC article.

7

MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphoma.

Li B, Yan J, Phyu T, Fan S, Chung TH, Mustafa N, Lin B, Wang L, Eichhorn PJA, Goh BC, Ng SB, Kappei D, Chng WJ. Li B, et al. Among authors: eichhorn pja. Blood. 2019 Dec 5;134(23):2046-2058. doi: 10.1182/blood.2019000381. Blood. 2019. PMID: 31434700 Free article.

8

Deciphering the roles of lncRNAs in breast development and disease.

Richard JLC, Eichhorn PJA. Richard JLC, et al. Among authors: eichhorn pja. Oncotarget. 2018 Feb 28;9(28):20179-20212. doi: 10.18632/oncotarget.24591. eCollection 2018 Apr 13. Oncotarget. 2018. PMID: 29732012 Free PMC article. Review.

9

Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma.

Saei A, Eichhorn PJA. Saei A, et al. Among authors: eichhorn pja. Cancers (Basel). 2019 Aug 14;11(8):1176. doi: 10.3390/cancers11081176. Cancers (Basel). 2019. PMID: 31416288 Free PMC article. Review.

10

Response to: USP26 regulates TGF-β signalling by deubiquitinating and stabilizing SMAD7; not applicable in glioblastoma.

Kit Leng Lui S, Iyengar PV, Jaynes P, Isa ZFBA, Pang B, Tan TZ, Eichhorn PJA. Kit Leng Lui S, et al. Among authors: eichhorn pja. EMBO Rep. 2020 Jan 7;21(1):e47269. doi: 10.15252/embr.201847269. Epub 2019 Dec 20. EMBO Rep. 2020. PMID: 31858684 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters